Medical devices; Mammography Quality Standards Act of 1992; inspection fees--FDA. Notice.
The Food and Drug Administration (FDA) is announcing the new fees the agency will assess for inspections of mammography facilities starting on February 13, 1998. The Mammography Quality Standards Act of 1992 (the MQSA) requires FDA to assess and collect fees from mammography facilities to cover the costs of annual inspections required by the MQSA. Because these costs have increased since inspections began in 1995, FDA is raising the fees accordingly. This notice explains which facilities are subject to payment of inspection fees, provides information on the costs included in developing inspection fees, and provides information on the inspection, billing, and collection processes. This is the first increase in inspection fees under the MQSA since the initial fee was established in 1995.
D000068:Accreditation / Q000191:economics; D000554:Ambulatory Care Facilities / Q000191:economics / Q000331:legislation & jurisprudence / Q000592:standards*; D002568:Certification / Q000191:economics; D005249:Fees and Charges / Q000331:legislation & jurisprudence*; D005260:Female; D006801:Humans; D008327:Mammography / Q000592:standards*; D011785:Quality Assurance, Health Care / Q000191:economics / Q000331:legislation & jurisprudence; D014481:United States; D014486:United States Food and Drug Administration